Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%
- Check24 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%
- Check38 days agoChange DetectedVersion bumped to v3.0.2; previous v3.0.1 tag and the 'Back to Top' element were removed.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check52 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as specific drug information related to Quizartinib and resources for Acute Myeloid Leukemia. Notably, several previous entries have been removed, particularly related to genetic diseases and certain locations.SummaryDifference11%
- Check59 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.5%
Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.